SNCA iRNA compositions and methods of use thereof for treating or preventing SNCA-associated neurodegenerative diseases

NZ837490AUndeterminedALNYLAM PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
NZ837490
Authority / Receiving Office
NZ · NZ
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-10-01
Filing Date
2021-09-29
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.